Dicerna Pharmaceuticals Top Management
Dicerna Pharmaceuticals employs about 302 people. The company is managed by 26 executives with a total tenure of roughly 228 years, averaging almost 8.0 years of service per executive, having 11.62 employees per reported executive. Analysis of Dicerna Pharmaceuticals' management performance can provide insight into the company performance.
Douglas Fambrough CEO President CEO, Director |
David Madden Chairman Independent Chairman of the Board |
Dicerna |
Dicerna Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (10.43) % which means that it has lost $10.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (95.22) %, meaning that it created substantial loss on money invested by shareholders. Dicerna Pharmaceuticals' management efficiency ratios could be used to measure how well Dicerna Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Dicerna Pharmaceuticals Workforce Comparison
Dicerna Pharmaceuticals is one of the top stocks in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 178,355. Dicerna Pharmaceuticals adds roughly 302 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (64.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (62.88) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $62.88. Dicerna Pharmaceuticals Notable Stakeholders
A Dicerna Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Dicerna Pharmaceuticals often face trade-offs trying to please all of them. Dicerna Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Dicerna Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Douglas Fambrough | President CEO, Director | Profile | |
David Madden | Independent Chairman of the Board | Profile | |
Steven Kates | Vice President - Regulatory Affairs | Profile | |
Theodore Ashburn | Senior Vice President - Product Strategy & Operations | Profile | |
Hardean Achneck | Vice President Head of Medical Development | Profile | |
Regina Paglia | Senior Vice President of Human Resources | Profile | |
John Green | Interim CFO | Profile | |
Bob Brown | Chief Scientific Officer and Sr. VP | Profile | |
Bruce Peacock | Independent Director | Profile | |
Dennis Langer | Independent Director | Profile | |
Martin Freed | Independent Director | Profile | |
Kevin Buchi | Independent Director | Profile | |
Peter Kolchinsky | Independent Director | Profile | |
Brian Halak | Independent Director | Profile | |
Adam Koppel | Independent Director | Profile | |
Marc Kozin | Director | Profile | |
Stephen Hoffman | Independent Director | Profile | |
Anna Protopapas | Director | Profile | |
Cynthia Smith | Independent Director | Profile | |
Ralf Rosskamp | Chief Medical Officer | Profile | |
Rob Ciappenelli | Chief Commercial Officer | Profile | |
James Weissman | Chief Bus. Officer | Profile | |
Rebecca Peterson | Head of Corporate Communications | Profile | |
Robert Ciappenelli | Chief Commercial Officer | Profile | |
David Caponera | Head of Patient Advocacy and Patient Services | Profile | |
Pankaj Bhargava | Chief Medical Officer | Profile |
Dicerna Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Dicerna Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Dicerna Pharmaceuticals within its industry.Dicerna Pharmaceuticals Manpower Efficiency
Return on Dicerna Pharmaceuticals Manpower
Revenue Per Employee | 638.6K | |
Revenue Per Executive | 7.4M | |
Net Loss Per Employee | 412.1K | |
Net Loss Per Executive | 4.8M | |
Working Capital Per Employee | 164.1K | |
Working Capital Per Executive | 1.9M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Dicerna Stock
If you are still planning to invest in Dicerna Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dicerna Pharmaceuticals' history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |